CVD risk score
1 paper1 finding
- Humans1
Interventions
1Rosuvastatin + ezetimibe
upin humans1
1 study
Rosuvastatin + ezetimibe
upin humans1
Rosuvastatin + ezetimibe improves CVD risk score in humans.
“CVD risk scores improved and correlated with LDL-C reduction (D:A:D, r=0.74).”
Humansin PLWHfixed-dose combinationrosuvastatin 5 mg plus ezetimibe 10 mg daily6 monthsn = 32
Preprints.org2 Sep 2026Preprint
Latest
16 in 12 monthsInternational Journal of Preventive Medicine
Performance of Cardiovascular Disease (CVD) Risk Assessment Tools in Clinical Practice - Agreement Between Different CVD Risk Scores Among Patients Attending NCD Clinic in a Tertiary Care Setting: A Prospective Observational Study
Cohort study of 200 peopleCardiovascular disease
Preprints.org
Optimizing Cardiovascular Risk in PLWH: Real-World Efficacy and Lipid Kinetics of Fixed-Dose Combination Rosuvastatin/Ezetimibe
Preprint: cohort study of 43 peopleCardiovascular disease
Indian Journal of Community Medicine
Decade of Risk: Predicting Ten-year Cardiovascular Disease Events (Stroke/myocardial Infarction) in Hypertensive Patients at a Tertiary Care Institute in Jharkhand
Cross-sectional study of 365 peopleMyocardial infarction
European Journal of Preventive Cardiology
Predicted 10-Year Cardiovascular Disease Risk Reduction with Tirzepatide Use Over Three Years for Primary Prevention of Cardiovascular Disease in Obesity
Randomised trial in 2,539 peopleTirzepatide
GSA 2025 Abstract
The Sleep-Heart-Brain Connection: Sex-Specific Modifiable Risk Factors and Cognitive Impact in Mid-to-Late Life
Study in peoplePopulations
AAIC 2025 Abstract
Association of cardiovascular disease risk and blood biomarkers of Alzheimer's disease
Study in peoplePopulations
AHA Scientific Sessions 2025 Abstract
Performance of Cardiovascular Risk Prediction Models in Cancer Survivors: A Systematic Review and Meta-Analysis
ReviewBiomarkers
AHA Scientific Sessions 2025 Abstract
Differential impact of aging on cardiovascular disease risk in male military service members
Study in peopleBiomarkers
AHA Scientific Sessions 2025 Abstract
AI-CVD vs. PREVENT for Predicting Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis (MESA)
Study in peopleBiomarkers